BCYC
Bicycle Therapeutics Plc
NASDAQ · Healthcare · Biotechnology · GB
$3.72
+1.23%Margins
Gross margin
43.1%
EBITDA margin
-160.8%
EBIT margin
-189.5%
Net margin
-169.8%
FCF margin
-208.7%
-28.1%
Return on equity
-25.0%
Return on assets
-30.5%
Return on invested capital
0.14x
Asset turnover
-$174.8M
Cash from operations
$6.70
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026